Featured series 
Tag: Amyotrophic lateral sclerosis
-
Health
Another study links omega-3s and health
Alpha-linolenic acid — an omega-3 fatty acid found in many nuts, seeds, and oils — showed the strongest link to slowing the progression and premature death of people living with ALS.
-
Health
Blocking tau may help ALS patients
Mass. General study uncovers potential new treatment strategy for disease.
-
Science & Tech
Gut microbiome influences ALS outcomes
The researchers found that in mice with a common ALS genetic mutation, changing the gut microbiome could prevent or improve disease symptoms.
-
Health
Inflammatory processes may play role in ALS
Accumulating evidence suggests that inflammatory processes may play a role in the initiation and progression of amyotrophic lateral sclerosis (ALS).
-
Campus & Community
The ‘spiritual leader’ of WHRB
After 58 years of helping Harvard student radio station WHRB build toward excellence, David Elliott steps back to undergo ALS treatment.
-
Health
RNA errors linked to ALS and dementia
A new Harvard Medical School study shows how malfunctioning RNA may lead to ALS and a form of dementia.
-
Health
Compound protects nerve cells targeted by diseases
Harvard researchers have identified a compound that helps protect the cells destroyed by spinal muscular atrophy, the most frequent fatal genetic disease of young children.
-
Health
Medical hope on horizon
Stem cell science is accelerating development of therapies for diabetes, ALS, other diseases, researchers tell HUBweek sessions.
-
Health
Research suggests new avenues for attacking ALS
Harvard researchers have found evidence that bone marrow transplantation may one day be beneficial to a subset of patients suffering from ALS.
-
Health
Hope against disease targeting children
Harvard Stem Cell Institute researchers studying spinal muscular atrophy have found molecular changes that help trigger the genetic disease in children.
-
Health
Progress against ALS
Studies begun by Harvard Stem Cell Institute scientists eight years ago have led to a report that may be a major step in developing treatments for amyotrophic lateral sclerosis, or Lou Gehrig’s disease.
-
Health
New hope for treating ALS
Harvard stem cell scientists have discovered that a recently approved medication for epilepsy might be a meaningful treatment for amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease, a uniformly fatal neurodegenerative disorder.
-
Health
High-calorie feeding may slow progression of ALS
In a small study by Harvard-affiliated Massachusetts General Hospital, increasing the number of calories consumed by patients with amyotrophic lateral sclerosis (ALS) may be a relatively simple way of extending their survival.
-
Health
Big boost in drug discovery
Using a new, stem cell-based, drug-screening technology that could reinvent and greatly reduce the cost of developing pharmaceuticals, researchers at the Harvard Stem Cell Institute have found a compound that is more effective in protecting the neurons killed in amyotrophic lateral sclerosis than are two drugs that failed in human clinical trials.
-
Health
New avenue in neurobiology
Harvard stem cell biologists have proven that it is possible to turn one type of already differentiated neuron into another inside the brain, and their findings may have enormous implications for the treatment of neurodegenerative diseases.
-
Health
A treatment for ALS?
According to researchers, results from a meta-analysis of 11 independent amyotrophic lateral sclerosis (ALS) research studies are giving hope to the ALS community by showing, for the first time, that the fatal disease may be treatable.
-
Health
Link found between ALS and SMA
Scientists have long known the main proteins that lead to the development of amyotrophic lateral sclerosis (ALS) and spinal muscular atrophy (SMA), respectively. Now research shows that these two motor neuron diseases likely share a pathway that leads to the development of disease.
-
Health
Slowing ALS symptom progression
Harvard researchers find that treatment with dexpramipexole — a novel drug believed to prevent dysfunction of mitochondria, the subcellular structures that provide most of a cell’s energy — appears to slow symptom progression in the neurodegenerative disease amyotrophic lateral sclerosis (ALS).
-
Health
From skin cells to motor neurons
Harvard stem cell researchers have succeeded in reprogramming adult mouse skin cells directly into the type of motor neurons damaged in amyotrophic lateral sclerosis, best known as Lou Gehrig’s disease, and spinal muscular atrophy.
